Conservative Management and General Care of Patients with Acute Renal Failure

  • Vittorio E. Andreucci

Abstract

Physicians must bear in mind that prerenal ARF, if untreated, may progress to acute tubular necrosis [ATN] [1]. Thus, prerenal ARF must be treated as early as possible.

Keywords

Lactate Prostaglandin Epinephrine Catecholamine Myeloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andreucci VE, Dal Canton A. Can acute renal failure in humans be prevented? Proc EDTA 17: 123–132, 1980.Google Scholar
  2. 2.
    Kleeman CR, Narins RG. Diabetic acidosis and coma. In Clinical Disorders of Fluid and Electrolyte Metabolism, Maxwell MH, Kleeman CR (eds). New York: McGraw-Hill, 1980 (3rd ed), pp. 1339–1377.Google Scholar
  3. 3.
    Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine 60: 339–354, 1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Kopple JD, Blumenkrantz MJ. Total parenteral nutrition and parenteral fluid therapy. In Clinical Disorders of Fluid and Electrolyte Metabolism, Maxwell MH, Kleeman CR (eds). New York: McGraw-Hill, 1980 (3rd ed)pp. 413–498.Google Scholar
  5. 5.
    Feest TG. Low molecular weight dextran: A continuing cause of acute renal failure. Brit Med J 2: 1300, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Phillips SF. Water and electrolytes in gastrointestinal disease. In Clinical Disorders of Fluid and Electrolyte Metabolism, Maxwell MH, Kleeman CR (eds). New York: McGraw-Hill, 1980, (3rd edition) pp. 1267–1290.Google Scholar
  7. 7.
    Orloff MJ, Chandler JG. Fluid and electrolyte disorders in burns. In Clinical Disorders of Fluid and Electrolyte Metabolism, Maxwell MH, Kleeman CR (eds). New York: McGraw-Hill, 1972, (2nd edition) pp. 1043–1062.Google Scholar
  8. 8.
    Hartford CE. Burns. In 1983 Current Therapy, Conn HF (ed). Philadelphia: WB Saunders, 1983, pp. 913–922.Google Scholar
  9. 9.
    Planas M, Wachtel T, Frank H, Henderson LW. Characterization of acute renal failure in the burned patient. Arch Intern Med 142: 2087–2091, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Arieff AI. Principles of parenteral therapy. A Principles of parenteral therapy and parenteral nutrition. In Clinical Disorders of fluid and electrolyte metabolism, Maxwell MH, Kleeman CR (eds). New York: McGraw-Hill, 1972, (2nd ed) pp. 567–589.Google Scholar
  11. 11.
    Eble JN. A proposed mechanism for the depressor effect of dopamine in the anesthetized dog. J Pharmacol Exp Ther 145: 64–70, 1964.PubMedGoogle Scholar
  12. 12.
    Andreucci VE, Dal Canton A, Corradi A. Gli effetti della Norepinefrina sulle pressioni idrodinamiche corticali nei nefroni superficiali di ratti normali ed in ipotensione emorragica. Ateneo Parmense, Acta Bio-Med, 45: 113–129, 1974.Google Scholar
  13. 13.
    Andreucci VE, Dal Canton A, Corradi A, Stanziale R, Migone L. Role of the efferent arteriole in glomerular hemodynamics of superficial nephrons. Kidney Int 9: 475–480, 1976.PubMedCrossRefGoogle Scholar
  14. 14.
    Hardaker WT Jr, Wechsler AS. Redistribution of renal intracortical blood flow during dopamine infusion in dogs. Circ Res 33: 437–444, 1973.PubMedGoogle Scholar
  15. 15.
    Goldberg LI. Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol Rev 24: 1–29, 1972.PubMedGoogle Scholar
  16. 16.
    Goldberg LI. Dopamine. Clinical uses of an endogenous catecholamine. N Engl J Med, 291: 707–710, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Neiberger RE, Passmore JC. Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage. Kidney Int 15: 219–226, 1979.PubMedCrossRefGoogle Scholar
  18. 18.
    Reid PR, Thompson WL. The clinical use of dopamine in the treatment of shock. Johns Hopkins Med J 137: 276–279, 1975.PubMedGoogle Scholar
  19. 19.
    Chan L, Ledingham JGG, Dixon JA, Thulborn KR, Waterton JC, Radda GK, Ross BD. Acute renal failure: A proposed mechanism based upon 31p nuclear magnetic resonance studies in the rat. In Acute Renal Failure, Eliahou HE (ed). London: John Libbey, 1982, pp. 35–41.Google Scholar
  20. 20.
    Chan L, Ledingham JGG, Clarke J, Ross BD. The importance of pH in acute renal failure. In Acute Renal Failure, Eliahou HE (ed). London: John Libbey, 1982, pp. 58–61.Google Scholar
  21. 21.
    Bore PJ, Chan L, Sehr PA, Thulborn KR, Ross BD, Radda GK. Protection of kidney from ischemic acidosis: A new approach to renal preservation. Eur Surg Res 12(Suppl 1): 20–21, 1980.Google Scholar
  22. 22.
    Bore PJ, Sehr PA, Chan L, Thulborn KR, Ross BD, Radda GK. The importance of pH in renal preservation. Transpl Proc 13: 707–709, 1981.Google Scholar
  23. 23.
    Schrier RW: Acute renal failure. JAMA 247: 2518–2525, 1982.PubMedCrossRefGoogle Scholar
  24. 24.
    Henrich WL, Anderson RJ, Berns AS, McDonald KM, Paulsen PJ, Berl T, Schrier RW. Role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. J Clin Invest 61: 744–750, 1978.PubMedCrossRefGoogle Scholar
  25. 25.
    van Ypersele de Strihou C. Acute oliguric interstitial nephritis. Kidney Int 16: 751–765, 1979.Google Scholar
  26. 26.
    Minuth AN, Terrell JB Jr, Suki WN. Acute renal failure: A study of the course and prognosis of 104 patients and of the role of furosemide. Am J Med Sci 271: 317–324, 1976.PubMedCrossRefGoogle Scholar
  27. 27.
    Anderson RJ, Linas SL, Berns AS, Henrich WL, Miller TR, Gabow PA, Schrier RW. Nonoliguric acute renal failure. N Engl J Med 296: 1134–1138, 1977.PubMedCrossRefGoogle Scholar
  28. 28.
    Bichet DG, Burke TJ, Schrier RW. Prevention and pathogenesis of acute renal failure. Clin Exper Dial Apheresis 5: 127–141, 1981.Google Scholar
  29. 29.
    Kjellstrand CM. Ethacrynic acid in acute tubular necrosis. Nephron 9: 337–348, 1972.PubMedCrossRefGoogle Scholar
  30. 30.
    Muth RG. Furosemide in acute renal failure. In Proceedings of Acute Renal Failure Conference, Friedman EA, Eliahou HE (eds). Washington, DHEW Publication No (NIH) 74-608, 1973, pp. 245-263.Google Scholar
  31. 31.
    Brown CB, Cameron JS, Ogg CS, Bewick M, Stott RB. Established acute renal failure following surgical operations. In Proceedings of Acute Renal Failure Conference, Friedman EA, Eliahou HE (eds). Washington, DHEW Publication No (NIH) 74-608, 1973, pp. 187-208.Google Scholar
  32. 32.
    Epstein M, Schneider NS, Befeler B. Effect of intrarenal furosemide on renal function and intrarenal hemodynamics in acute renal failure. Am J Med 58: 510–516, 1975.PubMedCrossRefGoogle Scholar
  33. 33.
    Levinsky NG, Bernard DB, Johnston PA. Enhancement of recovery of acute renal failure; Effects of mannitol and diuretics. In Acute Renal Failure, Brenner BM, Stein JH (eds). New York: Churchill Livingstone, 1980, pp. 163–179.Google Scholar
  34. 34.
    Barcenas CG, Jones P, Salomon S, Van Reet R, Cooley DA. Cardiogenic acute renal failure (CARF) following open-heart surgery. Cardiov Dis 6: 298–307, 1979.Google Scholar
  35. 35.
    Cantarovich F, Locatelli A, Fernandez JC, Perez Loredo J, Cristhot J. Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J (Suppl) 47: 13–17, 1971.Google Scholar
  36. 36.
    Cantarovich F, Galli C, Benedetti L, Chena C, Castro L, Correa C, Perez Loredo J, Fernandez JC, Locatelli A, Tizado J. High-dose frusemide in established acute renal failure. Brit Med J 4: 449–450, 1973.PubMedCrossRefGoogle Scholar
  37. 37.
    Kleinknecht D, Ganeval D, Gonzales-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron 17: 51–58, 1976.PubMedCrossRefGoogle Scholar
  38. 38.
    Borirakchanyavat V, Vongsthongsri M, Sitprija V. Furosemide and acute renal failure. Postgrad Med J 54: 30–32, 1978.PubMedCrossRefGoogle Scholar
  39. 39.
    Lindner A, Cutler RE, Goodman WG. Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16: 158–166, 1979.PubMedCrossRefGoogle Scholar
  40. 40.
    Graziani G, Cairo G, Tarantino F, Ponticelli C. Dopamine and frusemide in acute renal failure. Lancet II: 1301, 1980.CrossRefGoogle Scholar
  41. 41.
    Henderson IS, Beattie TJ, Kennedy AC. Dopamine hydrochloride in oliguric states. Lancet 2: 827–828, 1980.PubMedCrossRefGoogle Scholar
  42. 42.
    Lucas A, Meignan M, Le Gall Jr, Tillement JP, Rapin M. Caractéristiques pharmacocinétiques d’une forte dose de furosémide dans l’insuffisance rénale aiguë. Biomédicine 24: 45–49, 1976.PubMedGoogle Scholar
  43. 43.
    Lindner A, Sherrard DJ, Shen F, Cutler RE. Dopamine and furosemide in acute renal failure. In Acute Renal Failure, Eliahou HE (ed). London: John Libbey, 1982, pp. 174–175.Google Scholar
  44. 44.
    Barry KG, Malloy JP. Oliguric renal failure. JAMA 179: 510–513, 1962.PubMedGoogle Scholar
  45. 45.
    Eliahou HE. Mannitol therapy in oliguria of acute onset. Brit Med J 1: 807–809, 1964.PubMedCrossRefGoogle Scholar
  46. 46.
    Luke RG, Linton AL, Briggs JD, Kennedy AC. Mannitol therapy in acute renal failure. Lancet 1: 980–982, 1965.PubMedCrossRefGoogle Scholar
  47. 47.
    Luke RG, Kennedy AC. Prevention and early management of acute renal failure. Postgrad Med J 43: 280–289, 1967.PubMedCrossRefGoogle Scholar
  48. 48.
    Luke RG, Briggs JD, Allison MEM, Kennedy AC. Factors determining response to mannitol in acute renal failure. Am J Med Sci 259: 168–174, 1970.PubMedCrossRefGoogle Scholar
  49. 49.
    Eneas JF, Schoenfeld PY, Humphreys MH. The effect of infusion of mannitol-sodium bicarbonate on the clinical course of myoglobinuria. Arch Intern Med, 139: 801–805, 1979.PubMedCrossRefGoogle Scholar
  50. 50.
    Warren SE, Blantz RC. Mannitol. Arch Intern Med 141: 493–497, 1981.PubMedCrossRefGoogle Scholar
  51. 51.
    Johnston PA, Bernard DB, Donohoe JF, Perrin NS, Levinsky NG. Effect of volume expansion on hemodynamics of the hypoperfused rat kidney. J Clin Invest 64: 550–558, 1979.PubMedCrossRefGoogle Scholar
  52. 52.
    Johnston PA, Bernard DB, Perrin NS, Levinsky NG. Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney. J Clin Invest 68: 127–133, 1981.PubMedCrossRefGoogle Scholar
  53. 53.
    Ng RCK, Suki WN. Treatment of acute renal failure. In Acute Renal Failure, Brenner BM, Stein JH (eds). New York: Churchill Livingstone, 1980, pp. 229–273.Google Scholar
  54. 54.
    Irvine ROH. Diet and drugs in renal acidosis and acid-base regulation. In Drug Affecting Kidney Function and Metabolism, Edwards KDG (ed). Basel: Karger, 1972, pp. 146–188.Google Scholar
  55. 55.
    de Wardener HE. The Kidney. An Outline of Normal and Abnormal Structure and function. Edinburgh: Churchill Livingston, 1973.Google Scholar
  56. 56.
    Andreucci VE. Chronic renal failure. In The Treatment of Renal Failure, Castro JE (ed). Lancaster: MTP Press Limited, 1982, pp. 33–167.Google Scholar
  57. 57.
    Barton CH, Vaziri ND, Ness RL, Saiki JK, Mirahmadi KS. Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. Arch Surg 114: 70–74, 1979.PubMedGoogle Scholar
  58. 58.
    Abouna GM, Veazy PR, Terry DB. Intravenous infusion of hydrochloric acid for treatment of severe metabolic alkalosis. Surgery 75: 194–202, 1974.PubMedGoogle Scholar
  59. 59.
    Garella S, Chang BS, Kahn SI. Dilution acidosis and contraction alkalosis: Review of a concept. Kidney Int 8: 279–283, 1975.PubMedCrossRefGoogle Scholar
  60. 60.
    Bushinsky DA, Gennari FJ. Life-threatening hyperkalemia induced by arginine. Ann Intern Med 89: 632–634, 1978.PubMedGoogle Scholar
  61. 61.
    Kunis CL, Lowenstein J. The emergency treatment of hyperkalemia. Med Clin North Am 65: 165–176, 1981.PubMedGoogle Scholar
  62. 62.
    Lee HA. The management of acute renal failure. In Acute Renal Failure, Chapman A (ed). Edinburgh: Churchill Livingstone, 1980, pp. 104–124.Google Scholar
  63. 63.
    Cox M, Sterns RH, Singer I. The defense against hyperkalemia: The roles of insulin and aldosterone. N Engl J Med 299: 525–532, 1978.PubMedCrossRefGoogle Scholar
  64. 64.
    De Fronzo R, Felig P, Ferrannini E, Wahren J. Effects of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 238: F421–F427, 1980.Google Scholar
  65. 65.
    Berlyne GM, Janabi K, Shaw AB. Dangers of Resonium A in the treatment of hyperkalemia in renal failure. Lancet 1: 167–170, 1966.PubMedCrossRefGoogle Scholar
  66. 66.
    Whelton A, Schach von Witenau M, Twomey TM, Gordon Walker W, Bianchine JR. Doxycycline pharmacokinetics in the absence of renal function. Kidney Int 5: 365–371, 1974.PubMedCrossRefGoogle Scholar
  67. 67.
    Kleinknecht D, Ganeval D. Preventive hemodialysis in acute renal failure. Its effect on mortality and morbidity. In Proceedings of Acute Renal Failure Conference, Friedman EA, Eliahou HE (eds). Washington, DHEW Publication No (NIH) 74-608, 1973, pp. 165-185.Google Scholar
  68. 68.
    Larsson R, Bodemar G, Kagedal B. Effect of cimetidine, a new histamine H2-receptor antagonist, on renal function. Acta Med Scand 205: 87–89, 1979.PubMedCrossRefGoogle Scholar
  69. 69.
    Oken DE. On the differential diagnosis of acute renal failure. Am J Med 71: 916–920, 1981.PubMedCrossRefGoogle Scholar
  70. 70.
    McMurray SD, Luft FC, Maxwell DR, Hamburger RJ, Futty D, Szwed JJ, Lavelle KJ, Kleit SA. Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med 138: 950–955, 1978.PubMedCrossRefGoogle Scholar
  71. 71.
    Kjellstrand CM, Gornick C, Davin T. Recovery from acute renal failure. Clin Exper Dial Apheresis 5: 143–161, 1981.Google Scholar
  72. 72.
    Balslow JT, Jorgensen HE. A survey of 499 patients with acute anuric renal insufficiency. Am J Med 34: 753–764, 1963.CrossRefGoogle Scholar
  73. 73.
    Kennedy AC, Burton JA, Luke RG, Briggs JD, Lindsay RM, Allison MEM, Edward N, Dargie HJ. Factors affecting the prognosis in acute renal failure. Quart J Med 42: 73–86, 1973.PubMedGoogle Scholar
  74. 74.
    Kjellstrand CM, Casali RE, Simmons RL, Shideman JR, Buselmeier TJ, Najarian JS. Etiology and prognosis in acute posttransplant renal failure. Am J Med 61: 190, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Vittorio E. Andreucci

There are no affiliations available

Personalised recommendations